With South Florida facing the threat of a second Zika outbreak this summer, the University of Miami Miller School of Medicine's Institute for Bioethics hosted an April 6 multidisciplinary forum for clinicians, public health professionals and government leaders on “Zika 2017: Where Do We Go Next?”
In what could be the first such tumor of its kind in a child under the age of 13, University of Miami Health System surgeons at Holtz Children’s Hospital recently saved the life of a little girl by removing a tennis-ball-sized paraganglioma body tumor from her carotid artery.
The University of Miami Miller School of Medicine will soon begin one of the nation’s first full-scale Zika vaccine clinical trials testing the National Institutes of Health’s (NIH) experimental DNA-based vaccine. As Miami-Dade County has been ground zero for the Zika virus outbreak in the U.S., testing the vaccine in an endemic region is critical to help determine the vaccine’s safety.
Lilian Abbo, M.D., associate professor of clinical infectious diseases at the Miller School of Medicine and Chief of Infection Prevention and Antimicrobial Stewardship for Jackson Health System, was an invited speaker at the prestigious British Society of Antimicrobial Chemotherapy Spring Conference in London. The subject was “The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections.”
Rosario Isasi Receives Prestigious Presidential Fellowship Initiative Award from the Chinese Academy of Sciences 04.06.2017
Rosario Isasi, J.D., MPH, research assistant professor in the Dr. John T. Macdonald Foundation Department of Human Genetics at the University of Miami Miller School of Medicine, has won the competitive Chinese Academy of Sciences President’s International Fellowship Initiative.
Renowned Neurology Researcher Dr. William Sheremata Passes Away – Just Hours After FDA Approves Ground-Breaking MS Drug 03.31.2017
William A. Sheremata, M.D., emeritus professor of neurology at the University of Miami Miller School of Medicine, passed away on March 29 – but not before learning that the Food and Drug Administration (FDA) approved a ground-breaking drug for multiple sclerosis.
An HIV testing project led by Sonjia Kenya, Ed.D., M.S., M.A., director of community health programs at Sylvester Comprehensive Cancer Center’s Jay Weiss Institute for Health Equity, is reaching increasing numbers of people thanks to help from medical students and other volunteers.
In the hopes of making a difference for critically ill, premature babies and their families, the local leadership of the Bank of America recently toured the University of Miami Miller School of Medicine Division of Neonatology, where unit renovations created by the generosity of the Bank of America Charitable Foundation were completed.
University of Miami Health System Starts Clinical Trial to Test Regenerative Treatment for Stroke 03.28.2017
The University of Miami Health System is starting a clinical trial to further evaluate the safety and efficacy of an investigational cell therapy for the treatment of chronic motor deficit following an ischemic stroke.
Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that p300, a protein that increases gene expression by attaching acetyl molecules to DNA, may stop myelodysplastic syndrome (MDS) from developing into acute myeloid leukemia (AML). The study was published in the journal Leukemia.